DOUGLAS BROWN: Open Payments
NPI 1750322004 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 37 payments from 6 companies in 2025. Trend: 2023 $453 · 2024 $712 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $376 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $283 |
| Braeburn Inc. | 3 | $77 |
| Gilead Sciences, Inc. | 2 | $45 |
| Indivior Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, BRIXADI, MAVYRET, SUBLOCADE, Qelbree.
Industry payments across VA — which companies pay providers there.
